NCT01592162 - Comparison of Different Propofol Formulations With or Without Remifentanil | Biotech Hunter

Enrollment

409

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions

Anesthesia

Interventions

DRUG

Propofol (Astra-Zeneca), NaCl 0.9%

propofol administered by a closed-loop system and saline

DRUG

propofol 1% (Astra-Zeneca) and remifentanil

propofol administered by a closed-loop system and remifentanil (2 ng/ml, target controled infusion)

DRUG

propofol 1% (Astra-Zeneca) and remifentanil

propofol administered by a closed-loop system and remifentanil (4 ng/ml, target controled infusion)

DRUG

Propofol (Astra-Zeneca), NaCl 0.9%

propofol administered by a closed-loop system and saline

DRUG

Propofol (Astra-Zeneca) and remifentanil

propofol administered by a closed-loop system and remifentanil (2 ng/ml, target controled infusion)

DRUG

Propofol (Astra-Zeneca) and remifentanil

propofol administered by a closed-loop system and remifentanil (4 ng/ml, target controled infusion)

DRUG

Propofol (B-Braun) and NaCl 0.9%

propofol administered by a closed-loop system and saline

DRUG

Propofol (B-Braun) and remifentanil

propofol administered by a closed-loop system and remifentanil (2 ng/ml, target controled infusion)

DRUG

Propofol (B-Braun) and remifentanil

propofol administered by a closed-loop system and remifentanil (4 ng/ml, target controled infusion)

Trial Locations (2)

25034

CHU Besançon, Besançon

92151

Hopital Foch, Suresnes

All Listed Sponsors

lead

Hopital Foch

OTHER